News

The first in vitro diagnostic device that uses blood samples to detect Alzheimer disease has been granted marketing clearance by the US Food and Drug Administration.
A federal deadline ending the sale of off-brand weight-loss and diabetes medications is now in effect, cutting off access to drugs many patients count on.
A new White House report says today’s children are the sickest generation in US history when it comes to chronic disease, and it puts the blame on environmental toxins, poor nutrition and too much ...
Some of the nation's top brain researchers are still facing layoffs, even after US Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. said no working scientists would be cut.
The US Food and Drug Administration (FDA) has granted full approval to Novavax’s COVID-19 vaccine, but only for certain ...
Telangiectatic capillaries may have potential clinical relevance for diagnosis and treatment of diabetic macular edema.
The US Food and Drug Administration (FDA) has decided that only seniors and people at high risk should get the latest COVID-19 booster shots this fall.
The US Food and Drug Administration (FDA) has ordered Pfizer and Moderna to expand their warning labels on COVID-19 vaccines.
US News & World Report has released its new over-the-counter (OTC) medicine and health product rankings for 2025.
Exposure to nucleoside reverse transcriptase inhibitors (NRTIs), which treat HIV and hepatitis B and inhibit inflammasome activation, is associated with a significantly lower incidence of Alzheimer ...
Most Americans surveyed said they do not support the Trump administration’s recent cuts to staff and spending at federal health agencies.
The Food and Drug Administration (FDA) has approved Susvimo ® (ranibizumab injection) for the treatment of patients with diabetic retinopathy who have previously responded to at least 2 intravitreal ...